David_Shiers
@Davidiris1
Followers
2K
Following
2K
Media
341
Statuses
5K
Honorary reader in early psychosis Manchester Uni. Former GP and joint lead on UK EI in Psychosis Programme (2004-10); just my views
UK
Joined June 2013
‘Flattened, fattened, and forgotten’: the ‘dis-integrated’ care of patients prescribed #antipsychotics in the UK https://t.co/vNjVcVdOiO - a follow up editorial to our recent paper in @BJGPjournal on antipsychotic use in #primarycare UK ( https://t.co/4ewg6UYoMz)
#mentalhealth
bjgp.org
Background Long-term use of antipsychotics confers increased risk of cardiometabolic disease. Ongoing need should be reviewed regularly by psychiatrists. Aim To explore trends in antipsychotic...
0
4
5
Our guideline for the use of metformin to prevent antipsychotic-induced weight gain has just been published in Schizophrenia Bulletin. Read the full paper here: https://t.co/ov7R3rjTy6 A 🧵of the key points
6
17
31
This is the first guideline produced by the PROGRESS research group. Lead by @BNODonoghue and funded by @hrbireland
1
3
6
The one-page algorithm also lists important prescribing information including dosing instructions, possible side effects and monitoring recommendations
1
3
7
We also recommend more intensive treatment if the person is overweight or obese. That is, to start a GLP-1 agonist if the person meets the criteria according to the license if these medicines are available
1
3
6
3 core recommendations: 1: Co-commence metformin with high-risk antipsychotics (olanzapine,clozapine) 2: Co-commence metformin with medium risk antipsychotics + additional risk factors 3: Commence metformin with any antipsychotic if >3% increase in body weight in 1st year
1
2
5
Weight gain is one of the most common and distressing side-effects of antipsychotic medicines. But, co-commencement of metformin with can reduce the extent of weight gain by 4.03kg (95% CI -5.78kg to -2.28kg) compared to controls
1
2
5
This is the first published guideline for metformin for the prevention of weight gain. We used AGREE II & GRADE methods. International experts in endocrinology, metabolic psychiatry, pharmacy, general practice and patient & public partners came together to agree recommendations.
1
2
4
Take a screenshot 📸 to save the algorithm to your phone now
1
7
15
Thank you to all of our collaborators @ucddublin @SJOGMHealth @svuh @hrbireland @BNODonoghue @doloreskeating @RCSIPharmBioMol @HynesCaroline @OSheaHoganLab @FGaughran @JohnLyne9 @KarOConnor @benjmnperry @tobypill @Davidiris1 and many more
0
1
5
🚨🚨🚨New guidelines on access to dental care for people with #SevereMentalIllness from @BSSCD_uk, endorsed by @rcpsych Poor oral health is source of preventable suffering in this population and we can do better. @JouryEaster @Davidiris1 @DrLadeSmith
https://t.co/ZEwOFCZjWn
0
9
14
Our main Early Youth Engagement (EYE-2) in first-episode psychosis services trial paper is now out. You can read it here https://t.co/lbKpTfpXyW
@pfrench123 @EmmanuellPeters @BLennox4 @drlouisecjohns @hambahamba01 @Research_SPFT @NIHRresearch @Sussex_Psych @McPinFoundation
cambridge.org
The Early Youth Engagement (EYE-2) intervention in first-episode psychosis services: pragmatic cluster randomised controlled trial and cost-effectiveness evaluation - Volume 226 Issue 3
0
6
7
BJGPLife: Coping with Psychosis and Schizophrenia: Family Stories of Hope and Recovery https://t.co/6Vp2WUOCxk
1
4
4
Improvements for patients with #psychosis and early intervention in psychosis services are highlighted in this research https://t.co/j3PESzoQ1G
@EXTENDEIP @CizCG @Keele_MHRes
#PrimaryCare #EarlyInterventionInPsychosis Watch the 1-min video
1
4
7
another reason we should look after the physical health of people w SMI @Davidiris1
Our new paper out @BJGPjournal @juanbazoa @drandyclegg @osborn_ucl @i_petersen @UCL_PCPH @CAPS_UCL @NIHRresearch
0
2
7
Our new paper out @BJGPjournal @juanbazoa @drandyclegg @osborn_ucl @i_petersen @UCL_PCPH @CAPS_UCL @NIHRresearch
People over the age of 50 who have severe mental illness are more likely than the general population to experience fragility fractures, but may be less likely to get a diagnosis for osteoporosis, finds a new study led by Dr @CAvgerinou @UCL_IEHC
1
4
10
Thrilled to share that the systematic review conducted as part of my PhD has been published! 🎉 A big thank you to all my supervisors and collaborators who supported me along the way. Check it out here: https://t.co/6tUALUyweF Here are our key findings…
mdpi.com
Pharmacogenomic (PGx) testing can help personalise psychiatric prescribing and improve on the currently adopted trial-and-error prescribing approach. However, widespread implementation is yet to...
2
13
49
People taking long term antipsychotics need access to regular medication review to miminise physical health risks. We need to work together to make sure this is available for everyone who needs it. #parityofesteem #mortalitygap
@DrLadeSmith @rcpsych
https://t.co/Hm4jvqainV
bjgp.org
Background Long-term use of antipsychotics confers increased risk of cardiometabolic disease. Ongoing need should be reviewed regularly by psychiatrists. Aim To explore trends in antipsychotic...
13
31
78
On Tuesday, Dr Juliana Onwumere, @davidiris1, Prof Elizabeth Kuipers & family carers Abi & Annette discussed the 'hidden voices' of #carers for those with #psychosis, chaired by @northactually. To wrap up #WorldMentalHealthDay, here's a preview of the conversation⤵️
1
4
9
On 20th September 2024, The Hub for Metabolic Psychiatry officially launched alongside @MHPlatform! In our inaugural blog post for #worldmentalhealthday 🌍 we share some highlights from the event as well as some of our Hub's key aims. Read more 👇 https://t.co/xsZ9EvE72B
0
2
4